19
Participants
Start Date
June 30, 2005
Primary Completion Date
June 30, 2010
Study Completion Date
May 16, 2018
anti-thymocyte globulin
peripheral blood lymphocyte therapy
fludarabine phosphate
methylprednisolone
thiotepa
allogeneic hematopoietic stem cell transplantation
in vitro-treated peripheral blood stem cell transplantation
total-body irradiation
University of Florida Health Science Center - Gainesville, Gainesville
Childrens Hospital Los Angeles, Los Angeles
Massachusetts General Hospital, Boston
Children's Hospital Boston, Boston
Dana Farber Cancer Institute, Boston
M. D. Anderson Cancer Center at University of Texas, Houston
National Cancer Institute (NCI)
NIH
National Institute of Allergy and Infectious Diseases (NIAID)
NIH
Dana-Farber Cancer Institute
OTHER